The New York Times > Health > F.D.A. Approves Monthly Osteoporosis Pill: "A once-a-month pill to help women battle the bone-weakening disease osteoporosis has been approved by the Food and Drug Administration.

The drug, Boniva, will be the first monthly osteoporosis medication, said Dr. Ronald Emkey of Radiant Research in Reading, Pa., which conducted trials of the drug. Current medications are taken weekly.

Boniva was approved late Thursday, and it is being jointly promoted by the makers, GlaxoSmithKline and Roche.

The companies estimate that 44 million Americans older than 50 suffer from osteoporosis.

Also known as ibandronate sodium, Boniva, in 150 milligram tablets, is intended for treating and preventing postmenopausal osteoporosis.

The makers expect the medication to go on sale, by prescription, next month.

The companies said a support program would help patients remember to take the drug every month."

LINK

MSN Health- LINK : "The findings 'point out that this transport system [nerve cell signaling] gets disrupted in Alzheimer's"

LINKAmericans' struggles with memory loss may be getting worse, particularly as life expectancies rise.

link

Yahoo! LINK

LINKPeople who eat significant amounts of the omega-3 fatty acid docosahexanoic acid (DHA) may be less likely to get Alzheimer's disease, suggests an animal study. The study is be reported in the 30 March issue of The Journal of Neuroscience.

drug discovery@nature.comA brain scan developed in mice could herald a safe and affordable way to screen patients for Alzheimer's disease before they show any symptoms.

LINK:

LINK:

LINK

MayoClinic.com - Coronary bypass surgery: How many bypasses can you have?

link